XML 19 R48.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2013
Stock-Based Compensation  
Schedule of stock-based compensation expense, within salaries and employee benefits

 

(in thousands)

 

2013

 

2012

 

2011

 

Stock-based compensation expense before income taxes

 

$

1,940

 

$

1,481

 

$

1,165

 

 

 

 

 

 

 

 

 

 

 

 

Deferred tax benefit

 

679

 

518

 

408

 

 

 

 

 

 

 

 

 

Reduction of net income

 

$

1,261

 

$

963

 

$

757

 

Schedule of assumptions used in option and SAR valuations

 

Assumptions 

 

2013

 

2012

 

2011

 

 

 

 

 

 

 

 

 

Dividend yield

 

2.80

%

2.52

%

2.48

%

Expected volatility

 

22.54

%

22.04

%

22.64

%

Risk free interest rate

 

1.26

%

1.44

%

2.90

%

Forfeitures

 

6.40

%

4.20

%

6.07

%

Expected life of options (in years)

 

6.6

 

7.6

 

7.5

 

Schedule of stock option and SARs activity and related information

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Weighted

 

 

 

Weighted

 

average

 

 

 

 

 

 

 

average

 

Aggregate

 

average

 

remaining

 

 

 

Options

 

Exercise price

 

exercise

 

intrinsic

 

fair

 

contractual

 

(in thousands, except price and years)

 

and SARs

 

per share

 

price

 

value

 

value

 

life (years)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

At December 31, 2012

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested and exercisable

 

681

 

$

20.17-26.83

 

$

23.42

 

$

271

 

$

5.33

 

3.5

 

Unvested

 

246

 

21.03-26.83

 

22.62

 

77

 

4.67

 

7.9

 

Total outstanding

 

927

 

20.17-26.83

 

23.21

 

348

 

5.15

 

4.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

54

 

22.89

 

22.89

 

484

 

3.61

 

 

 

Exercised

 

(180

)

20.17-26.83

 

21.71

 

1,124

 

4.81

 

 

 

Forfeited

 

(4

)

21.03-23.76

 

22.78

 

32

 

4.88

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

At December 31, 2013

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested and exercisable

 

579

 

20.25-26.83

 

23.83

 

4,685

 

5.43

 

3.4

 

Unvested

 

218

 

21.03-24.87

 

22.70

 

2,011

 

4.36

 

7.7

 

Total outstanding

 

797

 

20.25-26.83

 

23.52

 

$

6,696

 

5.14

 

4.6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested during year

 

79

 

21.03-24.87

 

22.56

 

$

743

 

4.81

 

 

 

Schedule of restricted common stock activity

 

 

 

 

 

Grant date

 

 

 

 

 

weighted-

 

 

 

Number

 

average cost

 

Unvested at December 31, 2010

 

81,682

 

$

21.58

 

Shares awarded

 

41,991

 

23.96

 

Restrictions lapsed and shares released to employees/directors

 

(21,333

)

21.82

 

Shares forfeited

 

(7,333

)

22.61

 

Unvested at December 31, 2011

 

95,007

 

$

22.49

 

Shares awarded

 

57,156

 

22.71

 

Restrictions lapsed and shares released to employees/directors

 

(30,782

)

22.66

 

Shares forfeited

 

(7,471

)

22.59

 

Unvested at December 31, 2012

 

113,910

 

$

22.55

 

Shares awarded

 

55,275

 

22.93

 

Restrictions lapsed and shares released to employees/directors

 

(39,909

)

22.29

 

Shares forfeited

 

(4,720

)

23.45

 

Unvested at December 31, 2013

 

124,556

 

$

22.77

 

Schedule of RSU grants

 

 

 

 

 

 

 

Expected

 

 

 

Vesting

 

 

 

shares

 

Grant

 

period

 

Fair

 

to be

 

year

 

in years

 

value

 

awarded

 

2011

 

3

 

$

21.99

 

16,857

 

2012

 

3

 

20.57

 

22,668

 

2013

 

3

 

20.38

 

28,579

 

Schedule of options and SARs outstanding

 

Expiration

 

Number of
options and
SARs
outstanding

 

Options and
SARs
exercisable

 

Weighted average
exercise price of
options and SARs
outstanding

 

 

 

 

 

 

 

 

 

2014

 

92

 

92

 

22.69

 

2015

 

1

 

1

 

20.90

 

2016

 

144

 

144

 

24.07

 

2017

 

120

 

120

 

26.81

 

2018

 

73

 

73

 

23.37

 

2019

 

77

 

60

 

22.14

 

2020

 

77

 

45

 

21.03

 

2021

 

62

 

25

 

23.78

 

2022

 

97

 

19

 

22.87

 

2022

 

54

 

 

22.89

 

 

 

797

 

579

 

$

23.52

 

Schedule of number of shares to be issued upon exercise of outstanding stock-based awards and remaining shares available for future issuance

The following table provides detail of the number of shares to be issued upon exercise of outstanding stock-based awards and remaining shares available for future issuance under all the Bancorp’s equity compensation plans as of December 31, 2013.

 

Plan category (shares in thousands)

 

Number of
shares to be
issued upon
exercise

 

Weighted
average
exercise
price

 

Shares
available for
future
issuance (a)

 

 

 

 

 

 

 

 

 

Equity compensation plans approved by security holders:

 

 

 

 

 

 

 

Stock options

 

356

 

$

24.63

 

513

 

Stock appreciation rights (SARs)

 

(b)

 

(b)

 

(a)

 

Restricted stock

 

125

 

N/A

 

(a)

 

Restricted stock units

 

(c)

 

N/A

 

(a)

 

 

 

 

 

 

 

 

 

Total shares

 

481

 

 

 

513

 

 

(a)  Under the 2005 Stock Incentive plan, shares of stock are authorized for issuance as incentive and nonqualified stock options, SARs, restricted stock, and restricted stock units

(b)  At December 31, 2013, approximately 441,000 SARs were outstanding at a weighted average grant price of $22.63.  The number of shares to be issued upon exercise will be determined based on the difference between the grant price and the market price at the date of exercise.

(c)  The number of shares to be issued is dependend upon Bancorp achieving certain predefined performance targets and ranges from zero shares to approximately 110,000 shares.